Endocrinology Society Recognizes Neuroendocrine Cancer Physician and Researcher for Excellence at 2018 Annual Meeting

April 15, 2018

When Amit Tirosh, MD came to the United States in 2015 to be a senior endocrinologist at the National Institutes of Health (NIH), he began a journey that will lead full circle when he returns to Israel this summer to establish and lead a new neuroendocrine

READ MORE
Edward Wolin, MD joins Markey Cancer Center as Director of the Carcinoid and Neuroendocrine Tumor Program

June Luncheon with the Experts in New York City for the Neuroendocrine Tumor Community

April 3, 2018

Join neuroendocrine tumor (NET) patients in New York City on Sunday, June 10, 2018 for a unique opportunity to have lunch with two medical experts. Share your experiences with others who have similar concerns and hear from physicians on issues ranging…

READ MORE

PRRT – FDA Approves Lutathera®, What’s Next?

February 20, 2018

The FDA approval of Lutathera®, a peptide receptor radionuclide therapy (PRRT), on January 26, 2018 signals a new era in treatment options for the neuroendocrine cancer community.  It has also raised a host of questions including:

  • What exactly is
READ MORE

Zebra Tales: Carcinoid NETs Health Storylines Launches New Feature

February 15, 2018

Carcinoid NETs Health Storylines presents Zebra Tales! This brand new feature enables you to learn and share more about the experiences of others within the neuroendocrine tumor (NET) community.

Our first inspiring story is from Stacie Chevrier –…

READ MORE

FDA Approves LUTATHERA® for Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors

January 26, 2018

BREAKING NEWS: On January 26, 2018 the US Food and Drug Administration approved LUTATHERA® marking the first time a radioactive drug, or radiopharmaceutical, has been approved for the treatment of gastroenteropancreatic neuroendocrine tumors

READ MORE

News about Neuroendocrine Cancer Expert Physicians

January 8, 2018

Three appointments and a newly established one-year neuroendocrine tumor (NET) fellowship herald an exciting new year for several NET specialists.

Dr. Edward M. Wolin

Edward M. Wolin, MD, Co-Medical Director of the Carcinoid Cancer Foundation, has…

READ MORE
The late Monica Warner, a pioneer in carciniod and NET cancer patient advocacy

8th Annual Warner Advocacy Award: Call for Nominations

November 14, 2017

Novartis Oncology and The NET Alliance have announced that nominations are open for the 8th Annual Warner Advocacy Award. This annual award was established by Novartis in 2009 in honor of Monica Warner, who passed away in August 2009, to recognize…

READ MORE

NET Community Bicycle Raffle Recipients

November 10, 2017

In conjunction with Worldwide NET Cancer Awareness Day, November 10, the Carcinoid Cancer Foundation and Advanced Accelerator Applications are very excited to announce recipients of the recent Bicycle Giveaway Raffle.

Stefano Buono, CEO of Advanced…

READ MORE

Nutrition for Neuroendocrine Tumors and Carcinoid Syndrome: Find Foods You Love!

October 11, 2017

Are you wondering what are the best foods to eat if you have carcinoid syndrome?  What changes should you make to your diet if you have neuroendocrine tumors? The neuroendocrine tumor (NET) community is invited to attend a national webcast on Wednesday,

READ MORE

Free Kids’ Bicycles for the NET Cancer Community

September 22, 2017

Do you know a child in the NET cancer community – a child diagnosed with NET cancer or a child living in a family touched by NET disease – who would like to win a bicycle?  The Carcinoid Cancer Foundation and Advanced Accelerator Applications are partnering…

READ MORE